Impaired natural killer cell function in systemic lupus erythematosus. Relationship to interleukin-2 production. 1983

W L Sibbitt, and L Likar, and C W Spellman, and A D Bankhurst

Immune regulation requires clonal expansion of regulatory T cells which is dependent on the presence of interleukin-2 (IL-2). Previously, both natural killer (NK) cell function and IL-2 production were found to be depressed in systemic lupus erythematosus (SLE). This study was designed to determine the relationship between IL-2 production and NK cell activity in SLE. NK activity as determined by a standard 4-hour 51Cr-release assay was impaired in SLE (11.0 +/- 5.1 lytic units/10(7) cells) compared with controls (25.1 +/- 7.1 lytic units/10(7) cells) (P less than 0.05). IL-2 production was induced with concanavalin A and phorbol ester and quantitated using the IL-2 dependent cell line HT-2. IL-2 production was impaired in only 1 SLE patient, despite concomitant abnormalities in NK function in the SLE group as a whole. Moreover, in patients with impaired NK activity, incubation of lymphocytes with exogenous IL-2 did not restore NK activity to normal levels. These findings demonstrate that impaired NK activity in SLE is independent of IL-2 production and that defects in IL-2 production in SLE may not be as common as previously reported.

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

W L Sibbitt, and L Likar, and C W Spellman, and A D Bankhurst
February 1983, Journal of clinical & laboratory immunology,
W L Sibbitt, and L Likar, and C W Spellman, and A D Bankhurst
November 1979, Lancet (London, England),
W L Sibbitt, and L Likar, and C W Spellman, and A D Bankhurst
April 1986, Clinical and experimental immunology,
W L Sibbitt, and L Likar, and C W Spellman, and A D Bankhurst
August 1982, Annals of the rheumatic diseases,
W L Sibbitt, and L Likar, and C W Spellman, and A D Bankhurst
June 2009, Arthritis and rheumatism,
W L Sibbitt, and L Likar, and C W Spellman, and A D Bankhurst
January 1989, Clinical immunology and immunopathology,
W L Sibbitt, and L Likar, and C W Spellman, and A D Bankhurst
June 1992, Annals of the rheumatic diseases,
W L Sibbitt, and L Likar, and C W Spellman, and A D Bankhurst
November 1988, Clinical immunology and immunopathology,
W L Sibbitt, and L Likar, and C W Spellman, and A D Bankhurst
January 1980, Arthritis and rheumatism,
Copied contents to your clipboard!